Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix Launches Second Generation SENSUS Device

Business Wire March 18, 2014

NeuroMetrix Submits Regulatory Application for NC-stat DPNCheck in Japan

Business Wire March 11, 2014

NeuroMetrix CEO Dr. Shai N. Gozani Interviewed Live on TuDiabetes.org

Business Wire March 7, 2014

NeuroMetrix Reports Publication of Study Demonstrating that NC-stat DPNCheck is Effective at Detecting Diabetic Peripheral Neuropathy

Business Wire March 3, 2014

NeuroMetrix Reports Q4 and Full Year 2013 Results

Business Wire February 13, 2014

NeuroMetrix, Inc. Announces Date for 2013 Full Year and Fourth Quarter Financial Results Conference Call

Business Wire February 5, 2014

NeuroMetrix Announces Broad SENSUS Distribution Agreement with DJO Global

Business Wire February 4, 2014

NeuroMetrix Launches www.DPNCheck.com To Support Growing NC-stat DPNCheck Business

Business Wire January 27, 2014

NeuroMetrix and SENSUS Pain Management System Spotlighted in Several Media Outlets

Business Wire January 22, 2014

Jiro Nakamura M.D., Ph.D. Joins NeuroMetrix Scientific Advisory Board

Business Wire January 16, 2014

NeuroMetrix Previews Selected Highlights of Q4 2013

Business Wire January 13, 2014

NeuroMetrix to Partner with Omron Medical Devices for Distribution of NC-stat DPNCheck in China

Business Wire December 10, 2013

NeuroMetrix to Present at 7th Annual OneMedForum: Investing in Healthcare 2014

Business Wire December 4, 2013

NeuroMetrix Launches www.SENSUSRx.com

Business Wire November 22, 2013

CSCO, GCVRZ, CDW and NURO added to NASDAQ Active Stock Watch List at EPR

Accesswire November 14, 2013

TrendingWallStreet.com Announces High Volume Coverage on USU, NURO, HNR and JRCC

Accesswire November 14, 2013

NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum

Business Wire November 7, 2013

NeuroMetrix Reports Q3 2013 Results

Business Wire October 23, 2013

NeuroMetrix, Inc. Announces Date for 2013 Third Quarter Financial Results Conference Call

Business Wire October 16, 2013

NeuroMetrix Enters into Agreement with Rehabilitation Management Group, Inc. and OsteoArthritis Centers of America to Make SENSUS Pain Management System Available in its Affiliated Clinics

Business Wire October 15, 2013